What specific financial impact does Convatec expect from the Iran conflict in 2027, and how does it compare to its original forecast?

Convatec expects cost inflation to hit roughly 6% in 2027 — twice the 3% it had originally planned for — resulting in a $20 million to $30 million cost pressure next year, according to CEO Jonny Mason.

Why did Convatec's organic revenue growth slow to 1.6% for the four months ended April 30, 2026, and how is the company responding to maintain its full-year guidance?

The slowdown in organic revenue growth to 1.6% — down from 6.2% a year earlier — was mainly due to customers placing orders later in the year compared to last year; however, Convatec kept its 2026 outlook unchanged because it is 'largely hedged' for that year, and CEO Jonny Mason stated the company has 'enough plans, enough levers under our control' to absorb the cost pressure and still achieve its guidance.

Medical product maker Convatec warns of higher cost from Iran War

May 21, 2026

Convatec warned that the Iran conflict will increase 2027 costs by 6% due to rising oil prices impacting petroleum-derived plastics. Shares dropped 8% after the company forecasted $20 million to $30 million in additional cost pressure despite maintaining its 2026 outlook.

reuters

2026-05-21

Medical product maker Convatec warns of higher cost from Iran War

Medical product maker Convatec warns of higher cost from Iran War

FAQ